These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14908363)

  • 21. [Therapeutic use of streptomycin and conteben in childhood].
    WEINGARTNER L
    Kinderarztl Prax; 1950; 18():174-84. PubMed ID: 14785138
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aqueous solutions of conteben for intra-cavitary injection].
    POLSTER W
    Tuberkulosearzt; 1950 Oct; 4(10):594-5. PubMed ID: 14788310
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of two years experience with conteben (TBI/698) in the treatment of tuberculosis at the Freiburg (Breisgau) Medical Clinic and the St. Blasien Sanatorium].
    SCHAICH W; STADLER L; KEIDERLING W
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 104(6):465-514. PubMed ID: 14820733
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cross resistance between alpha-ethylthioiso-nicotinamide (Th 1314) and thiosemicarbazone (conteben)].
    BARTMANN K
    Tuberkulosearzt; 1960 Aug; 14():525-9. PubMed ID: 13687465
    [No Abstract]   [Full Text] [Related]  

  • 25. [Binding capacity of serum iodine in pulmonary tuberculosis during treatment with TbI-698 (conteben); a contribution to the significance of unsaturated fatty acids and to the mechanism of the therapeutic action of TbI in pulmonary tuberculosis].
    JENTGENS H; BREDE HD
    Munch Med Wochenschr; 1950 Aug; 92(19-20):766-7. PubMed ID: 14775625
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid.
    BERGQVIST N; DE MARE O
    Acta Med Scand; 1952 Aug; 143(5):323-35. PubMed ID: 12976024
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined conteben and PAS therapy of pulmonary tuberculosis].
    HANTSCHMANN L; WERNER R
    Arztl Wochensch; 1950 Jul; 5(29):525-8. PubMed ID: 15432230
    [No Abstract]   [Full Text] [Related]  

  • 28. [Roentgen control of the effectiveness of conteben therapy in pulmonary tuberculosis].
    HEINE F
    Dtsch Med Wochenschr; 1951 Feb; 76(8):240-5. PubMed ID: 14822706
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of conteben on pulmonary tuberculosis].
    UNVERRICHT W
    Arztl Wochensch; 1950 May; 5(18):284-7. PubMed ID: 15425394
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of pulmonary tuberculosis with Tb I/698 (conteben)].
    SCHMIEDT E; PFROGNER E
    Dtsch Gesundheitsw; 1950 Jun; 5(22):695-7. PubMed ID: 15427463
    [No Abstract]   [Full Text] [Related]  

  • 31. [USE OF THIOSEMICARBAZONE (CONTEBEN) AEROSOLS IN PULMONARY TUBERCULOSIS].
    MARTON S; KALLOES Z
    Tuberk Tudobetegsegek; 1964 Feb; 17():47-50. PubMed ID: 14186505
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of treatment of pulmonary tuberculosis with conteben].
    HEYMER A; KOESTER ED; STARKE O
    Minerva Med; 1950 Jul; 41(36):148-56. PubMed ID: 15438859
    [No Abstract]   [Full Text] [Related]  

  • 33. [Resorption of conteben and p-aminosalicylic acid following intracavitary instillation].
    WILDE W; RUCK KH
    Med Monatsschr; 1950 Aug; 4(8):601-3. PubMed ID: 15438651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intracavernous application of conteben in pulmonary tuberculosis; preliminary report].
    DOLKER B
    Tuberkulosearzt; 1952 Mar; 6(3):161-5. PubMed ID: 14958856
    [No Abstract]   [Full Text] [Related]  

  • 35. [Two years' sanatorium use of conteben].
    BRECKE F; BOHM F
    Hippokrates; 1950 Apr; 21(7):188-93. PubMed ID: 15421620
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of constitution and of conteben on the mortality in pulmonary tuberculosis in a sanitarium.
    MAULLCHE H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 107(3):183-93. PubMed ID: 12977706
    [No Abstract]   [Full Text] [Related]  

  • 37. Amithiozone: mechanism of action and resistance development by mycobacteria.
    TIRUNARAYANAN MO; VISCHER WA; BRUHIN H
    Am Rev Respir Dis; 1959 Oct; 80():559-68. PubMed ID: 13838487
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic studies on the 4-acetylaminobenzaldehyde-thiosemicarbazone (tibione) resistance in Mycobacterium tuberculosis var. hominis.
    TSUKAMURA M; NODA Y; YAMAMOTO M; HAYASHI M
    Jpn J Microbiol; 1959 Jan; 3():17-26. PubMed ID: 13839677
    [No Abstract]   [Full Text] [Related]  

  • 39. [On agranulocytosis, with special reference to its occurrence during conteben therapy; with a note on the problem of dosage].
    KOCH G
    Z Tuberk; 1951; 98(1-2):1-10. PubMed ID: 13029687
    [No Abstract]   [Full Text] [Related]  

  • 40. Thiacetazone in pulmonary tuberculosis.
    RAMSAY JH
    Edinb Med J; 1951 Jan; 58(1):29-35. PubMed ID: 14822908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.